Can smartphones and wearables unlock the secrets of atrial fibrillation?

NCT ID NCT04404465

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This study aims to better understand atrial fibrillation (AFib), the most common abnormal heart rhythm. Researchers will use mobile devices like ECG patches and a smartphone app to monitor heart rhythm, activity, and sleep in 3,000 adults, some with AFib and some without. Participants will also provide blood and saliva samples and undergo annual heart imaging for three years. The goal is to find markers that can predict who will develop AFib, whose condition will worsen, or who will respond best to treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to better ways to predict who is at risk for atrial fibrillation and who will respond best to treatment.
What could go wrong
This is an observational study, not a treatment trial, so it will not directly test any new therapy. The findings may not lead to immediate clinical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of California, San Francisco

    San Francisco, California, 94143, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.